JESSICA DITTO: Open Payments
NPI 1659434736 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 20 payments from 9 companies in 2025. Trend: 2023 $225 · 2024 $455 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $115 |
| Collegium Pharmaceutical, Inc. | 3 | $70 |
| Tris Pharma Inc | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: REXULTI, Jornay PM, Dyanavel XR, Qelbree, LYBALVI, CAPLYTA, VRAYLAR, Auvelity.
Industry payments across MD — which companies pay providers there.
